• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Good news for NF patients with low grade glioma (LGG)

Bioengineer by Bioengineer
April 1, 2020
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Investments in LGG research to transform patient care: Congratulations to Gilbert Family Foundation for sponsoring first-rate consensus workshop and gratitude to Synodos LGG donors

IMAGE

Credit: CTF

A paper published in the academic journal Neuro-Oncology by NF experts has demonstrated an increased understanding of low grade gliomas (LGG) occurring in children and adults with NF1. While the biology of LGG has become better known over the past decade, the complexities of these tumors have inhibited practical application of this knowledge to NF1 related LGGs, which can potentially impact close to a third of NF1 patients. According to Dr. Roger Packer, the Gilbert Family Foundation consensus conference held last year with NF1 and LGG experts was aimed at pulling together NF and low grade glioma experts to assess whether new therapeutic strategies could be developed for patients with LGG.

The paper can be accessed here: https://bit.ly/2UvCnD1

In response to the timing of the meeting, Dr. Packer said that “the LGG Synodos teams, funded by CTF had collaborated to analyze for the first time in NF history a large enough number of specimens to draw some important conclusions which probably will have implications in how LGG patients will be treated going forward.”

###

For the full interview with Dr. Packer – please click here: https://youtu.be/OC6knETKk_k

We would like to thank all the donors to the Synodos for LGG project, with special thanks to the lead funders Jim Bob & Laurée Moffett, Flashes of Hope and Cure NF with Jack. They believed in our audacious global collaborative projects and stepped up to fund this effort.

And, thanks to the Synodos teams who relentlessly work together to generate the data that will help NF patients, and who have made all data openly available on the CTF-funded NF Data Portal.

Media Contact
Simon Vukelj
[email protected]

Original Source

https://www.ctf.org/news/good-news-for-nf-patients-with-low-grade-glioma-lgg

Related Journal Article

http://dx.doi.org/10.1093/neuonc/noaa036

Tags: BiologyClinical TrialsGeneticsMedicine/HealthPediatricsPharmaceutical Science
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Biological Control Flies: Deterrents Against Adelges tsugae

August 24, 2025
Discovering Maize Height Traits Under Water Conditions

Discovering Maize Height Traits Under Water Conditions

August 24, 2025

Influence of Diet and Rumen Source on Fermentation

August 24, 2025

Early Dinosaur Skull Lesions Suggest Aggressive Behavior

August 24, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    121 shares
    Share 48 Tweet 30
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evaluating Research Capacity in UK Local Authorities

Biological Control Flies: Deterrents Against Adelges tsugae

Seedling Success in Oromia’s Forest Restoration Efforts

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.